Cargando…
The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout
OBJECTIVE: This study examined the initial impact of a national BNT162b2 vaccine rollout on SARS-CoV-2 infections in Qatar. METHODS: All individuals who had completed ≥14 days of follow-up by 16 March 2021 after receiving the BNT162b2 vaccine were included. This study calculated incidence rates (IR)...
Autores principales: | Zaqout, Ahmed, Daghfal, Joanne, Alaqad, Israa, Hussein, Saleh A.N., Aldushain, Abdullah, Almaslamani, Muna A., Abukhattab, Mohammed, Omrani, Ali S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117665/ https://www.ncbi.nlm.nih.gov/pubmed/33992763 http://dx.doi.org/10.1016/j.ijid.2021.05.021 |
Ejemplares similares
-
Remdesivir for patients with Coronavirus disease 2019 pneumonia requiring high oxygen support
por: Alibrahim, Rim S., et al.
Publicado: (2022) -
Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents
por: June Choe, Young, et al.
Publicado: (2022) -
Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar
por: Zaqout, Ahmed, et al.
Publicado: (2022) -
BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity
por: Vizcarra, Pilar, et al.
Publicado: (2021) -
Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions
por: Haq, Hannah N., et al.
Publicado: (2022)